(Q51020810)

27 March 2018

title

Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment. (English)

1 reference

27 March 2018

mild cognitive impairment

1 reference

1 reference

2

1 reference

27 March 2018

Ruth L O'Gorman

4

1 reference

27 March 2018

Declan Murphy

6

1 reference

27 March 2018

Simon Lovestone

object named as

Simon Lovestone

7

0 references

author name string

Catherine M L Foy

1

1 reference

27 March 2018

Amanda Glover

3

1 reference

27 March 2018

Andrew Simmons

5

1 reference

27 March 2018

publication date

5 February 2011

1 reference

27 March 2018

published in

Brain Topography

1 reference

27 March 2018

volume

24

1 reference

27 March 2018

issue

3-4

1 reference

27 March 2018

page(s)

316-322

1 reference

27 March 2018

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

1H magnetic resonance spectroscopy in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Effects of estrogen replacement therapy on human brain aging: an in vivo 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Magnetic resonance spectroscopy in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

Simulation of MRI cluster plots and application to neurological segmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10548-011-0170-5

10.1007/S10548-011-0170-5

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018